As one of Sweden's most internationally renowned clinical researchers, Klareskog has identified key mechanisms for the onset of rheumatoid arthritis.

His efforts have led to a deepened and renewed understanding of how single lifestyle factors in intimate interaction with the patient's genetic constitution can cause immunological responses and give rise to various chronic inflammatory diseases. This research has contributed to the development of new successful treatments for rheumatoid arthritis, based on both cellular and molecular mechanisms. In addition, Klareskog has involved the patient in treatment and follow-up in an exemplary way. He has also successfully worked to bring together patient data into well-functioning databases, which creates better opportunities for faster development of new drugs for rheumatoid arthritis.

The prize was awarded at the Swedish Medical Society on 19 April 2010 at a half-day seminar organized in collaboration with the recipient.

Lars Klareskog

 Lars Klareskog has been a professor at Karolinska Institutet since 1993. He was previously Chairman of the Department of Clinical Immunology at Uppsala University. Klareskog has been a member of the Nobel Assembly since 1995 and was previously a member of the Nobel Committee. In 2002 he was President of the European Congress of Rheumatology. 

Lars Klareskog, KI